在体内药理动力学评估和在体内表征战略性优化的perphenazine-loaded纳米结构脂质载体用于鼻至脑向向
Yogeeta O Agrawal1, Tulshidas S Patil1, Kiran D Patil1
1Department of Pharmaceutics, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule, Maharashtra, India.
Recent patents on nanotechnology
|July 2, 2025
概括
这项研究开发了带有perphenazine的纳米结构脂质载体 (PPZ-NLCs),以增强抗精神病药物输送. 这种新型配方显著改善了芬 (PPZ) 的生物可用性和脑向性.
科学领域:
- 制药科学 制药科学
- 纳米技术纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 珀菲纳 (PPZ) 是一种治疗精神分裂症的抗精神病药物,由于第一通代谢,其口服生物利用性较差.
- 提高PPZ生物可用性和大脑输送对于有效的精神分裂症治疗至关重要.
研究的目的:
- 为了提高生物可用性,制定含纳的纳米结构脂质载体 (PPZ-NLCs).
- 评估开发的PPZ-NLCs的大脑准潜力.
主要方法:
- 使用高压均质化制备PPZ-NLC.
- 通过2^3的全因数设计实现了配方优化.
- 进行了体外药物释放和体内药理动力学研究.
主要成果:
- 优化的PPZ-NLCs表现出有利的特征:167.5nm大小,0.277 PDI,-28.8 mV Zeta潜力和98.6%的捕获效率.
- 试验室研究表明,PPZ释放时间长,符合希古奇模型.
- 在体内研究显示,半衰期 (t1/2),AUC0-∞和Cmax增加,表明生物可用性增加和排泄减少 (Kel).
结论:
- 纳米结构的脂质载体显著提高了perphenazine的生物可用性.
- 开发的PPZ-NLC显示出有效的脑准潜力.
- 这种新的配方可能是申请专利保护的候选者.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
308
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
308
Modified-Release Drug Delivery Systems: Bioavailability
119
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
119
Modified-Release Drug Delivery Systems: Site-Targeted
113
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
113


